Medtronic

Market context

Medtronic can connect robotic surgery with broad procedure coverage, hospital relationships, instruments and clinical support infrastructure.

Facts

• Website: https://www.medtronic.com
• HQ: Dublin, IE
• Founded: 1949
• Ticker: MDT / NYSE
• Segment: Surgical

Medtronic role in healthcare robotics

Medtronic is a global medical technology company with surgical robotics exposure through the Hugo robotic-assisted surgery system. Medtronic can connect robotic surgery with broad procedure coverage, hospital relationships, instruments and clinical support infrastructure.

• Target environment: Hospitals, surgical centers, rehabilitation settings, pharmacy operations, care providers and medical-device workflows.
• Deployment model: Healthcare robotics model built around devices, enabling technology, procedure support, care workflows or clinical automation.
• Customer context: Medical-device companies, hospitals, surgeons, care providers, rehabilitation teams, pharmacy operators and healthcare buyers.
• Workflow context: Procedure support, rehabilitation, care delivery, pharmacy automation, hospital logistics, clinical data capture and device-assisted workflows.
• Commercial maturity: Published company profile with public sources supporting its robotics-adjacent role; deployment depth varies by product line and customer evidence.
• Market position: Healthcare robotics and medical-automation participant with relevance to procedure, care or device workflows.
• Adoption constraints: Adoption depends on clinical validation, safety, workflow integration, regulatory clearance, purchasing cycles and service support.
• Adjacent context: Surgical robotics, rehabilitation robots, hospital automation, pharmacy automation, clinical devices and assistive technology.
• Source confidence: medium

Events

• 2026-05-20 - Partnership - Medtronic and Asan Medical Center partner on Hugo robotic surgery - The collaboration covers clinical research, education and technology development around Hugo RAS. The agreement followed Hugo regulatory approvals in Europe, Japan, Korea and the U.S. The partnership connects The company to a customer, supplier or channel for…
• 2026-02-17 - Deployment - Medtronic Hugo RAS performs first U.S. commercial surgery at Cleveland Clinic - The procedure was performed at Cleveland Clinic by Jihad Kaouk, MD. The patient underwent robotic-assisted prostatectomy and was discharged the next day. The deployment places The company's technology into commercial automation and autonomous-system workflows…
• 2025-12-03 - Regulatory - Medtronic receives FDA clearance for Hugo robotic-assisted surgery system - Medtronic received U.S. FDA clearance for the Hugo robotic-assisted surgery system for urologic procedures. The clearance was supported by the Expand URO clinical study in multi-port robotic-assisted urological surgery. The decision brings Hugo into the U.S.…
• 2025-10-08 - Regulatory - Medtronic starts U.S. Hugo RAS gynecology IDE study - The Embrace Gynecology study became Medtronic’s third U.S. IDE clinical study for Hugo RAS. Medtronic said the study supported its strategy to pursue multiple U.S. indications for Hugo RAS. The approval supports Medtronic starts U.S. Hugo RAS gynecology IDE s…
• 2025-04-26 - Market Signal - Medtronic Expand URO trial meets Hugo RAS safety and effectiveness endpoints - The study evaluated Hugo RAS for urologic surgical procedures in the United States. Medtronic said the results supported its submission pathway for Hugo RAS in urology. The transaction strengthens The company's ownership, capital or operating position in heal…
• 2022-10-19 - Regulatory - Medtronic expands Hugo approvals in Japan, Europe and Canada - The approvals included Japan MHLW approval for urological and gynecological indications. The same announcement included CE Mark and Health Canada expansions for general surgery or laparoscopic indications. The event adds concrete context for maritime autonomy…

Operations / Deployments

• 2026-02-17 - Deployment - Medtronic Hugo RAS performs first U.S. commercial surgery at Cleveland Clinic - The procedure was performed at Cleveland Clinic by Jihad Kaouk, MD. The patient underwent robotic-assisted prostatectomy and was discharged the next day. The deployment places The company's technology into commercial automation and autonomous-system workflows…

Team

• Geoff Martha - Chairman and Chief Executive Officer - Medtronic's surgical, spine and robotic-enabled therapy portfolio sits within the global medtech strategy.
• Scott Cundy - SVP and Chief Quality, Development, and Innovation Officer - The role connects to product development and innovation governance across Medtronic's device and surgical-technology portfolio.

Customers and deployments

• First Commercial Case - first U.S. commercial Hugo RAS surgery at Cleveland Clinic - 2026-02-17 - Cleveland Clinic - robotic-assisted surgery - Medtronic Hugo RAS performed its first U.S. commercial surgery at Cleveland…